These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 27457755

  • 21. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
    Song H, Nieto GR, Perez DR.
    J Virol; 2007 Sep; 81(17):9238-48. PubMed ID: 17596317
    [Abstract] [Full Text] [Related]

  • 22. Oral administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α alleviates clinical signs caused by respiratory infection with avian influenza virus H9N2.
    Rahman MM, Uyangaa E, Han YW, Kim SB, Kim JH, Choi JY, Yoo DJ, Hong JT, Han SB, Kim B, Kim K, Eo SK.
    Vet Microbiol; 2011 Dec 29; 154(1-2):140-51. PubMed ID: 21764226
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparative analysis of key immune protection factors in H9N2 avian influenza viruses infected and immunized specific pathogen-free chicken.
    Dai M, Li S, Keyi Shi, Sun H, Zhao L, Deshui Yu, Liao J, Xu C, Liao M.
    Poult Sci; 2021 Jan 29; 100(1):39-46. PubMed ID: 33357705
    [Abstract] [Full Text] [Related]

  • 27. Protection of chickens against H9N2 avian influenza virus challenge with recombinant Lactobacillus plantarum expressing conserved antigens.
    Yang WT, Yang GL, Shi SH, Liu YY, Huang HB, Jiang YL, Wang JZ, Shi CW, Jing YB, Wang CF.
    Appl Microbiol Biotechnol; 2017 Jun 29; 101(11):4593-4603. PubMed ID: 28353000
    [Abstract] [Full Text] [Related]

  • 28. Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection.
    Park JK, Lee DH, Cho CH, Yuk SS, To EO, Kwon JH, Noh JY, Kim BY, Choi SW, Shim BS, Song MK, Lee JB, Park SY, Choi IS, Song CS.
    Vet Microbiol; 2014 Mar 14; 169(3-4):211-7. PubMed ID: 24472228
    [Abstract] [Full Text] [Related]

  • 29. Protective efficacy of an inactivated vaccine against H9N2 avian influenza virus in ducks.
    Teng Q, Shen W, Liu Q, Rong G, Chen L, Li X, Chen H, Yang J, Li Z.
    Virol J; 2015 Sep 17; 12():143. PubMed ID: 26377565
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Genotypic evolution and epidemiological characteristics of H9N2 influenza virus in Shandong Province, China.
    Li Y, Liu M, Sun Q, Zhang H, Zhang H, Jiang S, Liu S, Huang Y.
    Poult Sci; 2019 Sep 01; 98(9):3488-3495. PubMed ID: 30941436
    [Abstract] [Full Text] [Related]

  • 32. Enhanced infection of avian influenza virus H9N2 with infectious laryngeotracheitis vaccination in chickens.
    Arafat N, Eladl AH, Marghani BH, Saif MA, El-Shafei RA.
    Vet Microbiol; 2018 Jun 01; 219():8-16. PubMed ID: 29778208
    [Abstract] [Full Text] [Related]

  • 33. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
    Singh SM, Alkie TN, Hodgins DC, Nagy É, Shojadoost B, Sharif S.
    Vaccine; 2015 Jul 31; 33(32):3947-52. PubMed ID: 26092309
    [Abstract] [Full Text] [Related]

  • 34. Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.
    Xu X, Qian J, Qin L, Li J, Xue C, Ding J, Wang W, Ding W, Yin R, Jin N, Ding Z.
    Virol Sin; 2020 Aug 31; 35(4):455-467. PubMed ID: 32274680
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Recombinant Lactobacillus plantarum expressing HA2 antigen elicits protective immunity against H9N2 avian influenza virus in chickens.
    Yang WT, Yang GL, Yang X, Shonyela SM, Zhao L, Jiang YL, Huang HB, Shi CW, Wang JZ, Wang G, Zhao JH, Wang CF.
    Appl Microbiol Biotechnol; 2017 Dec 31; 101(23-24):8475-8484. PubMed ID: 29090342
    [Abstract] [Full Text] [Related]

  • 37. Vaccine Efficacy Against a New Avian Influenza (H9N2) Field Isolate from the Middle East (Serology and Challenge Studies).
    Gharaibeh S, Amareen S.
    Avian Dis; 2015 Dec 31; 59(4):508-11. PubMed ID: 26629624
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.
    Chen H, Matsuoka Y, Swayne D, Chen Q, Cox NJ, Murphy BR, Subbarao K.
    Vaccine; 2003 Oct 01; 21(27-30):4430-6. PubMed ID: 14505926
    [Abstract] [Full Text] [Related]

  • 40. Trend of Changes in the Titer of Antibody against Avian Influenza Virus H9n2 during Raising Period in Vaccinated and Unvaccinated Broiler Farms in Qazvin Province, Iran: A Cohort Study.
    Mirzaiee K, Shoushtari A, Bokaie S, Fallah Mehrabadi MH, Peighambari SM.
    Arch Razi Inst; 2020 Mar 01; 75(1):9-16. PubMed ID: 32291997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.